Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
17
self-reported 11–50 band
Founded
2012
14 years
Registry matches
1
ABR
Office countries
1
1 address
Funding rounds
3
Non equity assistance · Aug 2024
Company type
Public Company
self-reported
Legal entity
1 brand → 1 possible registrationMatched by name against ABR, so this is a candidate list, not a confirmed identity. Confidence and match method are shown against every row.
SERVATUS LTD
ABN97160435254
Legal entities
Show as table · Servatus Ltd: 1 registry entity
| SERVATUS LTD | ABN 97160435254 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
We are a biopharmaceutical research and production company, based on the Sunshine Coast, Queensland. Established in 2012, we research, develop and produce high-quality, innovative, medical grade biopharmaceuticals based on the latest scientific research. Servatus has two drug research platforms: Engineered proteins for the treatment of autoimmune diseases, and microbial biotherapeutics for the treatment of inflammatory conditions and bacterial infections.
Our protein research focuses on improving specific characteristics of existing therapeutic proteins. We carefully select proteins with clear clinical utility, and through rational redesign of key features, we improve bioavailbility and biological potency. We then rapidly clone and express the proteins in amounts suitable for clinical use, thus providing faster, more effective treatment of chronic auto immune diseases, such as rheumatoid arthritis and psoriasis, with fewer undesirable side effects.
In parallel with our protein work, we also develop live microbial biotherapeutic treatments for microbiome-associated conditions, including but not limited to inflammatory bowel disease (IBD), arthritis, atopic dermatitis, and gastrointestinal infections (for example, C. diff and H.pylori infections). We utilise bacterial strains that have not been widely employed previously, but have demonstrated bioactive properties in the latest scientific research. These bacteria have been shown to inhibit pathogenic bacterial growth and infection, modulate immune responses, and regulate inflammatory signals. Bacterial candidates are developed to act directly at specific sites to treat specific ailments and diseases.
Servatus currently holds patents for numerous microbial biotherapeutics and engineered proteins for autoimmune disease treatments
Servatus Ltd derives its name from the patron saint St Servatus, a 4th century churchman and diplomat, who was invoked as a saint for his healing powers for a range of ailments.
#biotech
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AU14 lomandra crescent; Coolum Beach, Queensland 4573Primary
Grid intelligence Members
Funding
Last round · 18 August 2024Amount not recordedNon equity assistance · investor: Brisbane Medtech Accelerator
Rounds3
Round typeNon equity assistance · non-equity funding
Amount (USD)not recorded
Stage rank1
Investors named1
Since last round1 yr 5 mo
Funding
Show as table · 3 funding rounds
| Rounds | 3 |
|---|---|
| Axis | 2012 to 2026 |
| Non equity assistance · 18 Aug 2024 | not disclosed |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
Which legal entity operates under Servatus Ltd?
One Queensland entity on the ABR: SERVATUS LTD (ABN 97 160 435 254), medium confidence.
How many people work at Servatus Ltd?
17 counted staff profiles at January 2026, inside the self-reported 11–50 band.
Where does Servatus Ltd have offices?
One address on record, Australia only. Primary: 14 lomandra crescent, Coolum Beach, Queensland 4573.
Has Servatus Ltd raised funding?
Three rounds. Latest 18 August 2024: non equity assistance, investor Brisbane Medtech Accelerator, no amount recorded.
Which companies are listed alongside Servatus Ltd?
Eight peer profiles on record: Infensa Bioscience and Australian Biotherapeutics.